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Abstract
The enantioselective total synthesis of pironetin has been achieved in 11 steps from known aldehyde
2. The synthesis relies on the formation of 5 out of 6 stereocenters through titanium mediated iterative
aldol reactions. Key steps in this synthesis include an acetal aldol reaction to establish the
stereochemistry at C8 and C9, an acetate aldol reaction, and “Evans” syn aldol reaction.
In 1994, the Kobayashi and Yoshida groups independently isolated the α,β-unsaturated lactone
(-)-pironetin 1 from the fermentation broth of Streptomyces prunicolor PA-48153 and
Streptomyces sp. NK 10958.1 (-)-Pironetin, originally identified as a novel plant growth
inhibitor with immunosupressant activity,1b was later shown to possess antiproliferative
activity against several tumor cell lines.2 Further investigation established that (-)-pironetin
has a unique mode of action compared to other tubulin binding agents, in that it covalently
binds to the α subunit of tubulin.3
(-)-Pironetin consists of an α,β-unsaturated δ lactone possessing a linear alkyl chain containing
four contiguous stereogenic centers and a trans-olefin. To date, several other syntheses of (-)-
pironetin and its derivatives have been reported.4
Most recently, Cossy reported an approach to (-)-pironetin utilizing enantioselecive crotylation
and allylation methods,4m Enders and coworkers have disclosed a convergent total synthesis
relying on RAMP/SAMP hydrazone methodology,4l and Nelson and coworkers have
completed a total synthesis employing acyl halidealdehyde cyclocondensations to construct
the polypropionate units present in pironetin.4k
We have previously demonstrated the ability to execute iterative propionate aldol reactions for
the synthesis of complex polypropionates in the context of the completion of a formal synthesis
of deoxyerythronolide B.5 A key goal in our designed approach to (-)-pironetin was to take
advantage of an iterative aldol sequence that would exploit not only the syn aldol variant, but
also other variations of the titanium tetrachloride mediated aldol additions of N-
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polyketide frameworks found in natural products could be accessible through this technology
was seen as an important goal of the synthesis.
The use of chlorotitanium enolates of thiazolidinethione chiral auxiliaries allows access to
either “Evans” syn and “non-Evans” syn aldol adducts in high diastereosectivity simply by
changing the stoichiometry and nature of the amine base employed. This interesting tunability
can be rationalized by a highly ordered transition state, in which the sulfur can either coordinate
to the titanium metal center leading to “non-Evans” syn aldol adducts (Figure 1, A), or in the
case when a strongly coordinating amine ligand is used, inhibit the thiocarbonyl from chelating
to the metal center resulting in “Evans syn” aldol adducts (Figure 1, B).6
Access to β-hydroxyl carbonyl subunits such as 5, has proven more challenging with regard
to obtaining high levels of diastereoselectivity due to the lack of substitution at the α carbon
of the enolate, however, we recently reported the use of the mesityl-substituted
thiazoldinethione chiral auxiliary to access the β-hydroxyl carbonyl subunit in an efficient and
highly diastereoselective reaction. The high diastereoselectivity is thought to arise from a
highly ordered chair-like transition state (Figure 1, C), though a non-chelate boat-like transition
state cannot be ruled out (Figure 1, D).7
Direct access to the anti β-hydroxy aldol adducts is not currently possible using the
chlorotitanium enolates. Several alternative approaches have been developed to access the β-
hydroxy anti aldol adducts.8 Evans and coworkers have developed an anti aldol reaction
employing both oxazolidinones and thiazolidinethiones through the use of magnesium
enolates.8a,8b Although aromatic aldehydes give highly diastereoselective aldol reactions in
high yelds using this method, aliphatic aldehydes give significantly lower conversion. A viable
alternative to this method is the acetal aldol, developed by Urpi and coworkers, allowing access
to anti β-alkoxy-α-methyl aldol adducts.9 The high diasteroselectivity associated with the
acetal aldol is thought to arise through an open transition state, in which the oxacarbenium ion
is attacked from the less hindered face of the chelated Z enolate, in an antiperiplanar
arrangement (Figure 1, E).9
The Urpi anti acetal aldol seemed ideally suited to access the the anti subunit at C8-9 of
pironetin since a methoxy group, rather than a free hydroxyl group, resides at C9.9 Our strategy
to access pironetin thus relies on the formation of 5 out of the 6 stereocenters through titanium
tetrachloride mediated iterative aldol reactions5 utilizing the thiazolidinethione chiral auxiliary
to execute an anti propionate acetal aldol, an acetate aldol and a syn propionate aldol. Our
retrosynthetic analysis is outlined in Scheme 1. We envisioned formation of the Z-enoate of
1 through a modified Horner-Emmons reaction10 with aldehyde 8. Aldehyde 8 could be
synthesized via an “Evans” syn aldol reaction with aldehyde 10 and thiazoldidinethione 9.
Aldehyde 10 could be accessed via a highly diastereoselective acetate aldol reaction between
mesityl-substituted thiazolidinethione 11 and aldehyde 12. Aldehyde 12 would result from a
highly diastereoselective acetal aldol reaction between a chiral dimethylacetal 14 and
propionate 13. The stereocenter at C-10 would be set using an asymmetric alkylation, originally
developed by Evans.11
The synthesis commenced with treatment of known aldehyde 212 with MeOH and p-TsOH to
provide acetal 14. An acetal aldol reaction with the resultant dimethyl acetal 14 and propionate
13 according to the conditions described byUrpi,9 provided the methylated aldol adduct 15 in
a 64% yield with 98:2 dr. The reaction was optimized by employing an excess of the enolate
(2 equiv), and using SnCl4, as opposed to BF3-OEt2, as the Lewis acid. The stereochemical
outcome is further reinforced by the presence of the alpha stereocenter of the acetal resulting
in Felkin control.9b
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Reductive cleavage12 of the chiral auxiliary afforded aldehyde 12, which was subjected to an
acetate aldol reaction7 with thiazolidinethione 11 to afford alcohol 16 in 88% yield and 95:5
dr. An excess of the enolate (1.5 equiv.) was necessary to achieve complete conversion of the
aldehyde to the aldol adduct. Protection of alcohol 16 as its triethylsilyl ether delivered the
thiazolidinethione 17. Reductive removal of the auxiliary with diisobutylaluminum hydride
furnished aldehyde 10. Aldehyde 10 was then subjected to “Evans” syn aldol reaction
conditions6 employing an excess of the enolate of thione 9, affording aldol adduct 18 in >20:1
dr and a 65% yield. Silylation of the resulting alcohol provided triethylsilyl ether 19, which
was then exposed to diisobutylaluminum hydride to effect reductive cleavage of the chiral
auxiliary affording aldehyde 8. Thus, three iterative aldol reactions (8 steps overall) allowed
the incorporation of 5 of the stereocenters of pironetin affording aldehyde 8.
Aldehyde 8 was treated with excess phosphonate 20, to effect a modified Horner-Emmons
reaction to access α,β-unsaturated ester 21 as a 10:1 mixture of E/Z-isomers. Exposure of 21
to PPTS in 10:1 CH2Cl2/MeOH provided only the unprotected diol, however, upon heating
ester 21 with PPTS in 10:1 benzene/MeOH, both protecting groups were removed and
lactonization was induced to furnish (-)-pironetin 1 in 63% yield. Synthetic 1 was identical in
all aspects to the natural product.
In summary, the enantioselective total synthesis of (-)-pironetin has been completed in 11 steps
from previously prepared aldehyde 2 with an overall yield of 12.5%. In addition, the versatility
of chlorotitanium mediated asymmetric aldol reactions was demonstrated through a sequence
of steps to rapidly construct pironetin in a highly stereoselective fashion.
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Proposed transition states to access (A) “non-Evans” syn aldol adducts, (B) “Evans” syn aldol
adducts, (C) & (D) β-hydroxy aldol adducts, and (E) anti β-alkoxy-α-methyl aldol adducts.
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